jbmhealthcarelimited
- 经调整利润*增加149.5%至1.3亿港元- 旗舰品牌凭借高效策略引领增长- 建议派发末期股息每...
ACN Newswire (简体中文)
- 經調整利潤*增加149.5%至1.3億港元- 旗艦品牌憑藉高效策略引領增長- 建議派發末期股息每股4.05港仙 業績亮點 收益按年上升24.6%至6.5億港元經調整權益持有人應佔溢利*增長149.5%至1.3億港元董事會建議派發末期股息每股4.05港仙三大產品組合均實現良好增長勢頭旗艦品牌保濟丸及何濟公銷售錄得大幅增長中國跨境電商業務在多個平台持續增長香港, 2024年6月18日 - (亞太商訊) - 健倍苗苗(保健)有限公司(「健倍苗苗」或「公司」;股份代號:2161,連同其附屬公司統稱「集團」)為香港品牌保健品的領先營銷商及分銷商,集團今天公佈截至二零二四年三月三十一日止年度(「二零二四財年」或「報告期」)的全年業績。 報告期內,集團品牌醫療保健業務總收益錄得 6.5億港元,大幅增長24.6%。集團的毛利較去年同期增長64.5%至3.4億港元。經調整權益持有人應佔溢利*顯著增加149.5%至1.3億港元,主要由於零售市場氣氛整體改善,以及品牌藥類別主要品牌的營銷策略,尤其是保濟丸及何濟公。 董事會建議派發末期股息每股4.05港仙。包括已派付的中期股息每股3.45港仙,二零二四財年的股息總額為每股7.5港仙。 有效的品牌策略推動卓越表現 品牌藥分部的銷售收益顯著上升53.3%,主要受惠於何濟公產品的出色表現。何濟公是止痛退燒藥非處方類別中家喻戶曉的品牌。憑藉著有效的品牌市場策...
ACN Newswire (正體中文)
- Adjusted Profit* Surges 149.5% to HK$130.5 Million- Flagship Brands Spearhead Growth with Effective Strategies- Recommends Final Dividend of HK4.05 Cents Per Share KEY HIGHLIGHTS Year-on-year revenue increased by 24.6%, totalling HK$648.4 millionAdjusted profit attributable to equity shareholders* soared 149.5% to HK$130.5 millionThe Board recommends a final dividend of HK4.05 cents per shareAll three business segments exhibited robust growth momentumFlagship proprietary brands Ho Chai Kung and Po Chai Pills led with impressive growthCross-border e-commerce continued to grow on various platf...
ACN Newswire
Net Profit Triples to HK$62.5 MillionInterim Dividend of HK3.45 cents per shareStrong Revenue Growth and Improved MarginsDriven by Effective Brand Management Strategies Amid Market Recovery HONG KONG, Nov 22, 2023 - JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the interim results of the Group for the six months ended 30 September 2023 (the "Reporting Period"). KEY HIGHLIGHTS -- Revenue up by 38.0% to HK$326.8 million -- Gro...
ACN Newswire
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら